Surprisingly, inspection of the entire CIS list revealed only one other target gene with statistically significant correspondence to this pattern: intragenic insertions in Ikzf1 were significantly more abundant in CD2-Runx2 transgenic tumours than in the other three genotypes and showed more frequent representation in dominant clones (Figure 5). The gene discussed is IKZF1; the disease is in situ carcinoma.